Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Therapeutic Goods Act 1989
I, Andrea Kunca, Head, Office of Devices Authorisation, Therapeutic Goods Administration and delegate of the Secretary of the Department of Health for the purposes of section 42DK(2) of the Therapeutic Goods Act 1989, give notice that the representations described in paragraph A below, being representations that are necessary for the appropriate use of the therapeutic goods described in paragraph B below, may be included either on the label of the package of the goods or in information included in the package in which those goods are contained:
- Representations to the effect that the goods described in paragraph B below are effective to be used against:
- Rhinovirus type 39
- Rotavirus Wa
- Poliovirus Herpes Simplex Virus Type 1
- Herpes Simplex virus Type 2
- Adenbvirus Influenza Type A (PR8)
- Influenza Type A (H1N1)
- Rhinovirus Type 37
- Avian Flu Virus
- Cytomegalovirus
- Rotavirus SA11
- Coronavirus
- Pine O Cleen Glen 20 Surface Spray Disinfectant - Hospital Grade, With Claims, NonSterile, supplied by Reckitt Benckiser Pty Ltd (Aust R 208254)
Name: Andrea Kunca
Position: Delegate of the Secretary
Head, Office of Devices Authorisation
Therapeutic Goods Administration
Date: 9 May 2014